USPH — US Physical Therapy Income Statement
0.000.00%
Last trade - 00:00
- $1.52bn
- $1.69bn
- $604.80m
- 87
- 34
- 70
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 482 | 423 | 495 | 553 | 605 |
Cost of Revenue | |||||
Gross Profit | 112 | 98.4 | 117 | 112 | 122 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 415 | 357 | 422 | 496 | 552 |
Operating Profit | 67.4 | 65.9 | 72.6 | 56.8 | 52.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 70.9 | 65.5 | 73.2 | 55.6 | 49.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 57.3 | 52.5 | 57.9 | 43.4 | 37.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 40 | 35.2 | 40.8 | 32.2 | 28.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 31.3 | 31.8 | 31.1 | 29.3 | 18.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.45 | 1.88 | 2.3 | 2.8 | 2.18 |
Dividends per Share |